These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 25141889)
1. Cell replacement therapies: is it time to reprogram? Mikkers HM; Freund C; Mummery CL; Hoeben RC Hum Gene Ther; 2014 Oct; 25(10):866-74. PubMed ID: 25141889 [TBL] [Abstract][Full Text] [Related]
2. Converting cell fates: generating hematopoietic stem cells de novo via transcription factor reprogramming. Daniel MG; Lemischka IR; Moore K Ann N Y Acad Sci; 2016 Apr; 1370(1):24-35. PubMed ID: 26748878 [TBL] [Abstract][Full Text] [Related]
3. Stem cell-based therapies in Parkinson's disease: future hope or current treatment option? Loewenbrück K; Storch A J Neurol; 2011 May; 258(Suppl 2):S346-53. PubMed ID: 21437664 [TBL] [Abstract][Full Text] [Related]
11. Osteogenic stem-cell characterization and development: potentials for cytotherapy. Triffitt JT; Oreffo RO; Virdi AS; Xia Z Cytotherapy; 2001; 3(5):413-6. PubMed ID: 11953025 [TBL] [Abstract][Full Text] [Related]
12. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology. Liu Y; Deng W Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934 [TBL] [Abstract][Full Text] [Related]
13. [Current status and perspective on regenerative medicine for spinal cord injury using iPS cell]. Nakamura M; Toyama Y; Okano H Rinsho Shinkeigaku; 2013; 53(11):1013-5. PubMed ID: 24291863 [TBL] [Abstract][Full Text] [Related]
14. Stem cell therapy emerging as the key player in treating type 1 diabetes mellitus. Vanikar AV; Trivedi HL; Thakkar UG Cytotherapy; 2016 Sep; 18(9):1077-86. PubMed ID: 27424148 [TBL] [Abstract][Full Text] [Related]
16. Gene and Cell Therapy for β-Thalassemia and Sickle Cell Disease with Induced Pluripotent Stem Cells (iPSCs): The Next Frontier. Papapetrou EP Adv Exp Med Biol; 2017; 1013():219-240. PubMed ID: 29127683 [TBL] [Abstract][Full Text] [Related]
17. Induced pluripotency: history, mechanisms, and applications. Stadtfeld M; Hochedlinger K Genes Dev; 2010 Oct; 24(20):2239-63. PubMed ID: 20952534 [TBL] [Abstract][Full Text] [Related]
18. De novo generation of HSCs from somatic and pluripotent stem cell sources. Vo LT; Daley GQ Blood; 2015 Apr; 125(17):2641-8. PubMed ID: 25762177 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of human adipose-derived stem cells in neurological disorders. Chang KA; Lee JH; Suh YH J Pharmacol Sci; 2014; 126(4):293-301. PubMed ID: 25409785 [TBL] [Abstract][Full Text] [Related]